Efficacy, Pharmacokinetics and Safety of Testosterone

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Testicular Hypogonadism
Interventions
DRUG

Testosterone gel (FE 99903)

Trial Locations (1)

Unknown

AccuMed Research Associates, Garden City

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT01370369 - Efficacy, Pharmacokinetics and Safety of Testosterone | Biotech Hunter | Biotech Hunter